Institute of Medical Biology University of Tromsø Tromsø 9037 Norway.
Mediators Inflamm. 1994;3(5):347-52. doi: 10.1155/S0962935194000487.
The present study was performed to examine whether residues 36-62 of TNFalpha contain the chemotactic domain of TNFalpha, and whether the p55 and p75 TNF receptors are involved in TNFalpha induced chemotaxis. The chemotactic effect of TNFalpha on PMN was inhibited by the mAbs Hrt-7b and Utr-1, against the p55 and p75 TNF receptors, respectively. Both receptors may therefore be required for mediating the chemotactic effect of TNFcz. The synthetic TNFalpha 36-62, similar to TNFalpha, had chemotactic effects on both PMN and monocytes. The chemotactic activity of the TNFalpha 36-62 peptide on PMN, was inhibited by Htr-7b, Utr-1 and soluble p55 receptor, which shows that the peptide possessed the ability to induce chemotaxis through the TNF receptors. In contrast to TNFalpha, the peptide did not show a cytotoxic activity against WEHI 164 flbrosarcoma cells. It is suggested that different domains of the TNFalpha molecule induce distinct biological effects.
本研究旨在探讨 TNFα 的 36-62 残基是否包含 TNFα 的趋化结构域,以及 p55 和 p75 TNF 受体是否参与 TNFα 诱导的趋化作用。抗 p55 和 p75 TNF 受体的 mAb Hrt-7b 和 Utr-1 均可抑制 TNFα 对 PMN 的趋化作用。因此,这两种受体可能都需要介导 TNFα 的趋化作用。与 TNFα 相似,合成的 TNFα 36-62 对 PMN 和单核细胞均具有趋化作用。抗 p55 和 p75 TNF 受体的 Htr-7b、Utr-1 和可溶性 p55 受体均可抑制 TNFα 36-62 肽对 PMN 的趋化活性,表明该肽通过 TNF 受体诱导趋化作用的能力。与 TNFα 不同,该肽对 WEHI 164 纤维肉瘤细胞没有细胞毒性作用。这表明 TNFα 分子的不同结构域诱导不同的生物学效应。